Future of Healthcare: Revolutionary Innovations Poised to Drive Sector Growth

Join the healthcare equity research team from Morningstar to consider how revolutionary changes in therapies, devices, and diagnostics are poised to drive growth and counter pricing pressure. From the GLP-1 market in biopharma to new procedures for atrial fibrillation and hypertension in medical devices, we’ll discuss several ongoing and potential sector drivers, along with the stocks that are best positioned to benefit from these trends.